Related Experiment Videos
Effect of atorvastatin on hs-CRP in acute coronary syndrome
Ankur Gupta1, Dinesh K Badyal, Prem P Khosla
1Department of Pharmacology, Christian Medical College and Hospital, Ludhiana-141 008, India.
Aims:
To evaluate the effect of a lower dose (20 mg) of atorvastatin on hs-CRP concentrations in patients with ACS.
Methods:
Group A (n = 50) patients received atorvastatin 20 mg day(-1) for 4 weeks in addition to standard anti-anginal treatment. Group B (n = 50) patients received standard anti-anginal treatment without atorvastatin.
Results:
hs-CRP concentrations decreased in both groups, but the decrease was greater in group A. The decrease in hs-CRP was also significantly greater in the subgroups of smoking, hypertension and past history of cardiovascular disease with atorvastatin.
Conclusions:
The use of a lower dose (20 mg) of atorvastatin can offer an attractive approach for early treatment of patients with ACS.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies